[The role of long-acting release (LAR) depot octreotide as adjuvant management of short bowel disease].
about
Introduction of new and underutilized vaccines: sustaining access, disease control, and infrastructure development.Management and Complications of Short Bowel Syndrome: an Updated Review.Lack of immunity against rubella among Italian young adultsTeratology: from science to birth defects prevention.The epidemiological profile of rubella and congenital rubella syndrome in the United States, 1998-2004: the evidence for absence of endemic transmission.Genetic analysis of rubella viruses found in the United States between 1966 and 2004: evidence that indigenous rubella viruses have been eliminated.
P2860
[The role of long-acting release (LAR) depot octreotide as adjuvant management of short bowel disease].
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
[The role of long-acting relea ...... ement of short bowel disease].
@en
[The role of long-acting release
@nl
type
label
[The role of long-acting relea ...... ement of short bowel disease].
@en
[The role of long-acting release
@nl
prefLabel
[The role of long-acting relea ...... ement of short bowel disease].
@en
[The role of long-acting release
@nl
P2093
P2860
P356
P1433
P1476
[The role of long-acting relea ...... ement of short bowel disease].
@en
P2093
Efraín Gómez-Herrera
José Luis Gutiérrez-de la Rosa
José Manuel Hermosillo-Sandoval
Oscar Alejandro Farías-Llamas
P2860
P304
P356
10.3201/EID1011.040428
P407
P577
2004-09-01T00:00:00Z